Navigation Links
The Lancet Makes Research More Accessible for Healthcare Professionals With New App for iPad
Date:1/6/2012

LONDON, January 6, 2012 /PRNewswire/ --

The Lancet, the world's leading independent general medical journal, today announced its first app for iPad is now available on the App Store. The Lancet App is an innovative article-based navigation app that makes it easier for healthcare professionals (HCPs) to find the information they need quickly and efficiently from the convenience of their iPad.

"In this new mobile and tablet age, you have to think about how a doctor seeks and uses the information they need," explains Scott Virkler, SVP e-Products Global Medical Research, Elsevier Health Sciences. "iPad gave us the opportunity to rewrite the rules according to the needs of our readers and provide them a convenient solution. With this article-based navigation app, we've created an entirely new model that responds to our readers' need to get to the articles they want, when they want."

The app gives subscribers convenient access to the latest articles published in The Lancet, The Lancet Oncology, The Lancet Neurology and The Lancet Infectious Diseases. Articles are sent to users and categorized by topic for an easy, at-a-glance overview. Users can annotate articles, share them with colleagues and create alerts and bookmark favorites. They can also search the journal database from the app and download articles for immediate or future use, either on or offline. 

The Lancet App is one of many apps Elsevier is developing for healthcare professionals. "We have an extensive, robust mobile app development program," added Virkler. "Healthcare professionals are on the leading edge of this exciting new publishing medium."

The Lancet App is available for free from the App Store on iPad or at http://www.itunes.com/appstore. Selected content is available for all viewers. Subscribers to The Lancent have access to all published content.

Media contact
Tony Kirby
Media Relations Manager
The Lancet Press Office
32 Jamestown Road
Camden
London
NW1 7BY

Tel: +44(0)20-7424-4949
Mob: +44(0)7920-592635
E-mail: tony.kirby@lancet.com


'/>"/>
SOURCE Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet
2. The Lancets New Online Medical Journal Helps Clinicians and Medical Researchers Find Practice-Changing Evidence Quickly and Easily
3. Inverseons Asthma Therapy Receives Notice of Allowance; Clinical Trial Highlighted in Lancet
4. Research in Autism Encyclopedia Shows No Link to Children With Autism, Supports Lancet Retraction
5. Pirfenidone Phase 3 Results Published Today in The Lancet
6. Observant LLC Makes the 2008 Inc. 5000 List
7. Varian, Inc. Board of Directors Makes Officer Changes
8. Life Science Alley: R&D Makes German Medical Technologies Top in Europe
9. JMAR Technologies' Chief Scientist Invited by Pfizer Inc. to Speak at IFPAC -- BioSentry Makes Strides in Pharma Market
10. Advanced Instruments Makes Strategic Investment in Cantimer, Inc.
11. Nanotechnology makes supertelescopes much more sensitive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
Breaking Biology Technology:
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):